Senti Biosciences Inc. Revenue 2021–2025
Senti Biosciences Inc. annual/quarterly revenue history and growth rate from 2021 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Senti Biosciences Inc. revenue for the quarter ending March 31, 2026 was 16000.
- Senti Biosciences Inc. revenue for the twelve months ending March 31, 2026 was 16000, a 99.19% decrease year-over-year.
- Senti Biosciences Inc. annual revenue for 2025 was 22000.
- Senti Biosciences Inc. annual revenue for 2024 was 0, a 100.00% decrease from 2023.
- Senti Biosciences Inc. annual revenue for 2023 was 2.0 M, a 39.81% decrease from 2022.
- Senti Biosciences Inc. annual revenue for 2022 was 3.3 M.
Senti Biosciences Inc. (SNTI) — Frequently Asked Questions
Senti Biosciences Inc. (SNTI) is a publicly traded US company. It has a market capitalization of $22M. In fiscal 2025 it reported revenue of $22,000 and net income of -$61M. Explore SNTI's stock price, financial statements, earnings history, margins and key ratios below.
What is Senti Biosciences Inc.'s market cap?
Senti Biosciences Inc. (SNTI) has a market capitalization of $22M.
What is the SNTI stock price?
SNTI trades at $0.96 (+5.97% on the day).
How much revenue does Senti Biosciences Inc. make?
Senti Biosciences Inc. reported revenue of $22,000 in fiscal 2025.
Is SNTI profitable?
In fiscal 2025, Senti Biosciences Inc. reported net income of -$61M.